Insider buys at MEIP
MEI Pharma CFO bought 12,500 shares
CFO Brian G. Drazba bought 12,500 shares for $1.6 per share on Dec. 19. Since then, the stock price has increased by 17.5%. MEI Pharma has a market cap of $138.471 million and its shares were traded around $1.88. The company has a price-sales ratio of 24.42.
MEI Pharma announced its third-quarter results with revenue of $1.16 million and gross profit of $469,000, while the net loss was $2.99 million. The 2019 total revenue was $4.92 million, a 203% increase from 2018. The gross profit was $652,000, a 137% increase from the year prior. The net loss was $16.82 million.
CEO Daniel P. Gold bought 18,750 shares for $1.6 per share on Dec. 19. Director Thomas C. Reynolds bought 10,000 shares and Director Frederick W. Driscoll bought 62,500 shares. Since then, the stock price has increased by 17.5%.
Bladerunner